Actively Recruiting
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Led by Guangzhou Concord Cancer Center · Updated on 2026-03-09
52
Participants Needed
2
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The above studies show that most of the supportive evidence for the reduction of toxicity and improvement of efficacy of proton therapy for recurrent Nasopharyngeal carcinoma(NPC) comes from various observational and retrospective studies, lacking high-level evidence-based medical evidence. The conduct of this study will explore the safety and efficacy of intensity-modulated proton radiotherapy for recurrent NPC and provide more high-quality evidence-based medical evidence for proton therapy of recurrent cancer.
CONDITIONS
Official Title
Proton Therapy for Recurrent Nasopharyngeal Carcinoma
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-metastatic squamous cell carcinoma of the nasopharynx confirmed by biopsy, stage 63; T2b and/or positive lymph nodes
- Pathological type WHO I-III
- Eastern Cooperative Oncology Group (ECOG) performance status score 0-1
- Age 18 years or older
- Expected survival of at least 6 months
- Tumor range and size evaluated before treatment
- Nutritional and physical condition able to tolerate recommended radiotherapy and chemotherapy
You will not qualify if you...
- Evidence of distant metastasis at stage IVc
- Recurrence isolated to cervical lymph nodes
- Participation in other interventional tumor trials
- History of other malignant tumors within past 5 years (excluding melanoma skin cancer) or untreated active infections
- Tumors originating from the head and neck region not treated
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Guangzhou Concord Cancer Center
Guangzhou, Guangdong, China
Actively Recruiting
2
Guangzhou concord cancer center
Guanzhou, Guangzhou, China
Actively Recruiting
Research Team
T
Taize Yuan, M.D., Ph.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here